Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Robotic Radical Perineal Prostatectomy Study

NCT: NCT04919057 · WITHDRAWN

NCT IDNCT04919057
StatusWITHDRAWN
Start Date2025-07-01
Completion2026-03-31
SponsorChinese University of Hong Kong (OTHER)
First posted
Last updated

Brief Summary

Radical perineal prostatectomy (RPP) was the first approach utilized for the removal of the entire prostate gland for prostate cancer. In the minimally invasive surgery era, the robotic-assisted laparoscopic prostatectomy (RALP) was first described in the early 2000s, and has become the mainstay of prostatectomy in Hong Kong and many parts of the world. Incorporating the robotic technology into the technique of RPP has been studied recently. Some preliminary data showed that such approach resulted in a better functional outcome in continence and erectile function. Our study aims at assessing the safety and effectiveness of robotic RPP in prostate cancer management.

Frequently Asked Questions

What is Robotic Radical Perineal Prostatectomy Study?

Robotic Radical Perineal Prostatectomy Study is a clinical trial registered under NCT04919057. Current status: WITHDRAWN.

What is the status of NCT04919057?

The current status of NCT04919057 (Robotic Radical Perineal Prostatectomy Study) is: WITHDRAWN.

When did Robotic Radical Perineal Prostatectomy Study start?

Robotic Radical Perineal Prostatectomy Study started on 2025-07-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.